State of the Art Symposium

SA 18 - New cancer screening programmes: upcoming European strategies

Lectures

1
Chairperson's introduction

Chairperson's introduction

05:00Milagros Otero Garcia, Vigo / ES

2
Better screening leads to better public health and less burden of cancer on society: the EU perspectives

Better screening leads to better public health and less burden of cancer on society: the EU perspectives

15:00Regina G. H. Beets-Tan, Amsterdam / NL

3
Prostate cancer screening: MRI and AI

Prostate cancer screening: MRI and AI

15:00Valeria Panebianco, Rome / IT, Emanuele Messina, Rome / IT

4
Lung cancer screening: LDCT and AI

Lung cancer screening: LDCT and AI

15:00Carlos Francisco Muñoz Nuñez, Valencia / ES

5
Colon cancer screening

Colon cancer screening

15:00Stuart Andrew Taylor, Prestwood / UK

6
Patient's perspective: theory and practice of early cancer detection

Patient's perspective: theory and practice of early cancer detection

10:00Erik Briers, Hasselt / BE

7
Panel discussion: What is the potential of early cancer detection to shape patients' futures?

Panel discussion: What is the potential of early cancer detection to shape patients' futures?

15:00Panel discussion: What is the potential of early cancer detection to shape patients' futures?

5 min
Chairperson's introduction
Milagros Otero Garcia, Vigo / Spain
15 min
Better screening leads to better public health and less burden of cancer on society: the EU perspectives
Regina G. H. Beets-Tan, Amsterdam / Netherlands
  1. To know the updated European Council recommendation on cancer screening.
  2. To learn about EU funding opportunities to support research evaluating new imaging technologies for early cancer detection.
  3. To understand why radiologists should be involved in multidisciplinary research and collaborate with stakeholders.
15 min
Prostate cancer screening: MRI and AI
Valeria Panebianco, Rome / Italy
Emanuele Messina, Rome / Italy
  1. To understand the need for MRI-based screening in prostate cancer.
  2. To provide an overview of MRI-based screening trials.
  3. To explore the role of AI and MRI in prostate cancer screening and its clinical implications.
15 min
Lung cancer screening: LDCT and AI
Carlos Francisco Muñoz Nuñez, Valencia / Spain
  1. To understand the underlying technology and methodology of LDCT in lung cancer screening.
  2. To explore the role of AI in enhancing the effectiveness and accuracy of LDCT in lung cancer screening.
  3. To evaluate the clinical impact and ethical implications of using AI in conjunction with LDCT for lung cancer screening.
15 min
Colon cancer screening
Stuart Andrew Taylor, Prestwood / United Kingdom
  1. To understand the European strategy on colorectal cancer screening.
  2. To appreciate the organisation of colorectal cancer screening programs based on FIT testing.
  3. To learn the role of the radiologist in colorectal cancer screening.
10 min
Patient's perspective: theory and practice of early cancer detection
Erik Briers, Hasselt / Belgium
  1. To understand that in prostate cancer, there are no preventative measures possible or known today.
  2. To learn that the only way to lower the number of patients diagnosed with metastatic disease is risk-based population screening using laboratory tests and mpMRI.
  3. To learn that the EU Council issued advice to work towards this and that the PRAISE-U is working fast to collect the necessary evidence to proceed to bring prostate cancer screening to the EU men.
15 min
Panel discussion: What is the potential of early cancer detection to shape patients' futures?

This session offers AI-generated subtitles.